Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jumpei Yoshida
Observed name:
J. Yoshida
Institutions:
Fujita Health University,
The Cancer Institute Hospital,
Nagoya Medical Center,
Japanese Foundation For Cancer Research
Observed institutions:
Fujita Health University,
The Cancer Institute Hospital,
Nagoya Medical Center,
Japanese Foundation For Cancer Research
ORCID:
0000-0001-5310-3423
Observed ORCID:
0000-0001-5310-3423
OpenAlex ID:
A5078824860
Adipsin-dependent adipocyte maturation induces cancer cell invasion in breast cancer
2024
·
Jumpei Yoshida
, Takanori Hayashi
, et al.
·
Scientific Reports
·
11
PDF
Efficacy of trastuzumab deruxtecan in an advanced gastric cancer patient with brain metastasis
2021
·
Jumpei Yoshida
, Keiji Sugiyama
, et al.
·
Current Problems in Cancer
·
9
Continuous administration of lenvatinib after first documented disease progression in patients with radioiodine-refractory thyroid cancer
2026
·
Naoki Fukuda
, Jumpei Yoshida
, et al.
·
Endocrine
·
1
Real-world platinum selection in immune checkpoint inhibitor-based therapy for recurrent or metastatic head and neck cancer: an exploratory multi-institutional retrospective study
2026
·
Jumpei Yoshida
, Naoki Fukuda
, et al.
·
Scientific Reports
·
1
PDF
Variant-Level Curation and Molecular Context of Therapeutically Relevant Alterations in Parathyroid Carcinoma: A Nationwide C-CAT Analysis in Japan
2026
·
Jumpei Yoshida
, Yasuyoshi Sato
, et al.
·
Research Square
PDF
Abstract 8492: Real-World Comparative Effectiveness of Nirsevimab and Palivizumab in High-Risk Infants: A Nationwide Propensity Score-Matched Study
2026
·
Takanori Suzuki
, Jumpei Yoshida
, et al.
·
Circulation
Association of antibiotic exposure with Kawasaki disease
2026
·
Takanori Suzuki
, Jumpei Yoshida
, et al.
·
Scientific Reports
PDF
Weight loss despite nutritional support predicts poor outcomes after postoperative chemoradiotherapy for high-risk head and neck cancer
2026
·
Yuka Inamochi
, Jumpei Yoshida
, et al.
·
Supportive Care in Cancer
PDF
Durable disease control following multidisciplinary treatment including pembrolizumab in POLE-mutated dedifferentiated endometrial carcinoma with brain metastases: A case report
2026
·
Takumi Ito
, Jumpei Yoshida
, et al.
·
Medicine
Abstract LB227: Adipokine adipsin promotes breast cancer progression by inducing adipocyte maturation
2026
·
Yohei Shimono
, Behnoush Khaledian
, et al.
·
Cancer Research
54P Impact of treatment sequence between immune checkpoint inhibitors and paclitaxel/cetuximab in recurrent or metastatic head and neck cancer
2026
·
E. Toda
, J. Yoshida
, et al.
·
ESMO rare cancers.
PDF
Thyroid cancer risk among socially and economically active individuals exposed to antibiotics: a large population-based study in Japan
2026
·
Jumpei Yoshida
, Takanori Suzuki
, et al.
·
SSRN Electronic Journal
683P Platinum selection in pembrolizumab–based therapy for recurrent or metastatic head and neck cancer
2025
·
J. Yoshida
, N. Fukuda
, et al.
·
Annals of Oncology
Sporadic medullary thyroid carcinoma with a rare RET transmembrane domain mutation (A641R) that responds to selpercatinib
2025
·
Naoki Fukuda
, Kazuhisa Toda
, et al.
·
The Oncologist
PDF
Efficacy of Combined Dabrafenib and Trametinib Therapy in BRAFV600E Mutant Intrahepatic Cholangiocarcinoma with a Neurofibromatosis Type 2 Mutation
2025
·
Jumpei Yoshida
, Keiji Sugiyama
, et al.
·
Internal Medicine
PDF
Abstract LB078: Adipocytes promote cancer stem cell properties and metastatic progression in breast cancers
2025
·
Yohei Shimono
, Masahiro Mizuno
, et al.
·
Cancer Research
Show more works
View as search
Works count:
16
Citation count:
22
H-index:
2
I10-index:
1
Year
Topic
Type